• Create account
  • Log in
Clinical Guidelines
  • Home
  • About
    • About the clinical guidelines
    • Declaring and dealing with competing interests
    • Frequently asked questions
    • Guideline journal articles
  • CCA guidelines
    • Barrett's Oesophagus
    • Bowel cancer
      • Colorectal cancer
      • Surveillance colonoscopy
    • Endometrial cancer
    • Cervical cancer screening
    • Lung cancer
      • Lung cancer prevention & diagnosis
      • Lung cancer treatment
    • Prostate cancer
      • Advanced prostate cancer
      • PSA testing
    • Sarcoma
    • Skin cancer
      • Melanoma
      • Keratinocyte cancer (non-melanoma)
    • Pain management
    • Archive of CCA guidelines
  • COSA guidelines
    • Adolescents and Young Adult (AYA) guidelines
      • AYA cancer fertility preservation
      • AYA early cancer detection
      • AYA psychosocial management
    • Cancer therapy medication safety
    • Gastroenteropancreatic neuroendocrine tumours
    • Head & neck cancer nutrition
    • Teleoncology
  • Hosted
    • Childhood Brain Tumour or Leukaemia
  • National Cancer Prevention Policy
  • View
  • Code
  • History
  • Refresh
  • What links here
  • Related changes
  • Special pages
  • Permanent link
  • Page information
  • Browse properties

CAPP2

From Cancer Guidelines Wiki
Jump to:navigation, search

CAPP2



Publications of this clinical trial

  1. Burn J, Bishop DT, Mecklin JP, Macrae F, Möslein G, Olschwang S, et al. Effect of aspirin or resistant starch on colorectal neoplasia in the Lynch syndrome. N Engl J Med 2008 Dec 11;359(24):2567-78 Available from: http://www.ncbi.nlm.nih.gov/pubmed/19073976. (compare appraisals of this publication)
    • Appraisal by Priyashiel.parikh (Outcomes- CRC incidence)
    • Appraisal by Albert.chetcuti (Outcomes- CRC incidence)
  2. Burn J, Gerdes AM, Macrae F, Mecklin JP, Moeslein G, Olschwang S, et al. Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet 2011 Dec 17;378(9809):2081-7 Available from: http://www.ncbi.nlm.nih.gov/pubmed/22036019. (compare appraisals of this publication)
    • Appraisal by Priyashiel.parikh (Outcomes- CRC incidence)
    • Appraisal by Albert.chetcuti (Outcomes- CRC incidence)
  3. x. x. x 2015 May;x. (compare appraisals of this publication)

Compare all appraisals of this clinical trial


Retrieved from "https://wiki.cancer.org.au/australiawiki/index.php?title=Clinical_trial:CAPP2&oldid=118522"
Cancer Council would like to acknowledge the traditional custodians of the land on which we live and work. We would also like to pay respect to the elders past and present and extend that respect to all other Aboriginal people.